SAM-e (S-Adenosylmethionine).
Methyl donor that rivals antidepressants Supplies the methyl groups your cells hand out in hundreds of reactions, which is the biochemistry behind its use for mood steadiness and joint comfort.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- DepressionJoint HealthLiver
What SAM-e (S-Adenosylmethionine) is, and what it does.
- Does it work
- Suits adults working on mood steadiness or joint comfort, and people whose folate and B12 intake runs thin. Talk to your doctor first if you take a serotonergic medicine.
- How much to take
- Start with 200mg a day. 200 to 800mg is the daily band where the methyl donor does its work, taken on an empty stomach alongside B12, folate and B6.
- Time to feel it
- Mood-related change is usually described at one to two weeks. Joint comfort takes longer, closer to four to eight weeks of daily use.
- The first dose
- Day one is quiet for most people, though a little stomach unease or a mild lift in alertness can show up. The methylation work is biochemical rather than felt.
- With regular use
- Most effects take 2-8 weeks. Be patient.
- How well tolerated
- Generally well tolerated. Check with your doctor if on medications.
- How it feels
- Mood lift within 1-2 weeks, joint improvements
- The overlooked benefit
- It also donates an aminopropyl group for spermidine and spermine, a polyamine route that supports normal cell renewal and produces no homocysteine at all.
400 to 800mg a day is where SAM-e (S-Adenosylmethionine) works.
Source: Sharma et al. 2017 Ann Gen Psychiatry review; Papakostas et al. 2010 Am J Psychiatry
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
SAM-e (S-Adenosylmethionine) has emerging evidence. Based on 15+ studies.
- Methyl group supply for methyltransferase reactionsNarrative review
- Mood steadinessMeta-analysis
- Joint comfort and mobilityRandomised trial
- Liver enzyme markersRandomised trial
- Homocysteine already in the normal rangeNarrative review
Questions people ask about SAM-e (S-Adenosylmethionine).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Tosylate and disulfate tosylate salts stabilise the identical S-adenosyl methionine molecule, differing in shelf stability rather than in what is absorbed. Listing both counts one active twice.
After SAMe donates its methyl group it becomes homocysteine, and 5-methyltetrahydrofolate is the donor that turns homocysteine back into methionine. Without folate that recycling loop stalls and homocysteine accumulates.
Folate carries the one-carbon unit that regenerates methionine, the precursor from which SAMe is made. The methionine and folate cycles are two halves of one loop.
Methionine synthase needs methylcobalamin to transfer the methyl group from folate to homocysteine. Low B12 traps folate in its methyl form and slows regeneration of the SAMe precursor.
Cystathionine beta-synthase and cystathionine gamma-lyase both use pyridoxal 5-phosphate to move homocysteine onward toward cysteine. B6 opens the exit route from the methionine cycle.
Betaine homocysteine methyltransferase uses betaine to remethylate homocysteine to methionine without folate or B12. It is the second and parallel route back to the SAMe precursor.
Methylenetetrahydrofolate reductase carries an FAD cofactor derived from riboflavin, and its activity is riboflavin sensitive, particularly in people with the common thermolabile variant. Riboflavin therefore sets how much methylfolate reaches the cycle.
SAMe is made by joining methionine to ATP, and that enzyme requires magnesium as part of the Mg-ATP complex. Magnesium status is a background condition for making SAMe endogenously.
The PEMT route makes phosphatidylcholine by transferring three methyl groups from SAMe, so dietary choline spares SAMe from that demand. Choline is also the precursor of betaine, which feeds remethylation.
Guanidinoacetate methyltransferase consumes a large share of the body's SAMe to make creatine. Supplying creatine directly reduces that demand and leaves more methyl capacity for other reactions.
Homocysteine produced downstream of SAMe can be converted through cystathionine to cysteine, the limiting residue for glutathione. NAC supplies that residue directly, so the two converge on the same pool.
Cysteine generated from the methionine cycle by way of SAMe is the rate-limiting input to glutathione synthesis. The two sit at opposite ends of one sulfur pathway.
5-HTP raises serotonin synthesis directly while SAMe supports monoamine methylation and turnover, so serotonergic tone can add up beyond what either label implies. This is a combination to disclose rather than promote.
St. John's Wort raises synaptic monoamine availability and induces CYP3A4, so pairing it with SAMe both adds serotonergic effect and shifts the clearance of other actives. Flag rather than stack.
Catechol-O-methyltransferase consumes a SAMe methyl group each time it inactivates a catecholamine made from tyrosine. More catecholamine turnover means more methyl demand on the same pool.
Methionine adenosyltransferase condenses methionine with ATP to make S-adenosylmethionine, so methionine is the direct precursor and ATP supply is the second input. Everything downstream of SAMe is limited by that step. Taking the finished molecule bypasses the step rather than adding to it.
Serine hydroxymethyltransferase moves a carbon from serine onto tetrahydrofolate, and that carbon is what eventually remethylates homocysteine back to methionine. Serine is the main dietary entry point for one-carbon units. Without it the folate cycle has less to hand over.
Homocysteine left after a methyl transfer can go down the transsulfuration route to cystathionine and then cysteine, and SAMe itself is the allosteric activator that opens that route at cystathionine beta-synthase. So SAMe status decides how much homocysteine is committed to cysteine rather than recycled. Cysteine then feeds glutathione synthesis.
Both transsulfuration enzymes, cystathionine beta-synthase and cystathionine gamma-lyase, require pyridoxal 5-phosphate. Without it, homocysteine cannot exit the cycle towards cysteine. The active coenzyme form is what the enzymes bind directly.
Cysteine produced by transsulfuration is oxidised through cysteine sulfinic acid to hypotaurine and then taurine. That places taurine two steps downstream of the same sulfur that SAMe hands off. The link is pathway position, not a measured combination effect.
Phosphatidylethanolamine N-methyltransferase adds three methyl groups in a row to make phosphatidylcholine, and each one comes from SAMe. That single enzyme is among the largest consumers of methyl groups in the liver. A formula that pushes membrane phospholipid synthesis is drawing on the same methyl pool.
The final step of melatonin synthesis is an O-methylation of N-acetylserotonin by acetylserotonin O-methyltransferase, and SAMe donates that methyl group. Methyl supply is therefore upstream of the finished hormone. This describes the pathway and does not imply that supplemental SAMe raises melatonin output.
Carnitine synthesis starts from trimethyllysine, made by three SAMe-dependent methylations of a protein-bound lysine residue. Methyl-group supply sits at the front of that pathway. Dietary carnitine bypasses it, which is why the relationship matters more to endogenous synthesis than to a supplemented intake.
Two steps in the ubiquinone biosynthetic sequence, catalysed by COQ3 and COQ5, are SAMe-dependent methylations that build the benzoquinone head group and its methoxy substituents. Methyl-donor supply is thus part of endogenous CoQ10 production. Supplemental CoQ10 enters downstream of those steps.
SAMe is decarboxylated to dcSAMe, which donates the aminopropyl group that spermidine synthase attaches to putrescine. That is a distinct fate from methyl donation and it consumes SAMe stoichiometrically. Polyamine synthesis and methylation therefore compete for the same molecule.
Nicotinamide N-methyltransferase methylates nicotinamide using SAMe, producing N1-methylnicotinamide for excretion. A large nicotinamide load therefore draws methyl groups away from other acceptors. This is a well-described competition for the shared methyl pool, and it runs in the other direction too.
Methionine synthase and betaine-homocysteine methyltransferase both use a zinc centre to activate the thiol of homocysteine before the methyl group is transferred. Zinc is structural to the chemistry, not incidental. Ordinary intakes cover it, so this describes the pathway rather than a supplementation pairing.
Glycine N-methyltransferase methylates glycine to sarcosine using SAMe, and it exists largely to burn off excess methyl groups and hold the SAMe to SAH ratio steady. It is one of the highest-capacity SAMe-consuming enzymes in the liver. Glycine supply is therefore part of how the body regulates rather than depletes methylation.
Nothing specific on file for SAM-e (S-Adenosylmethionine). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What SAM-e (S-Adenosylmethionine) actually does.
S-adenosylmethionine is the methyl donor for the great majority of methyltransferase reactions in human cells, covering DNA, histones, RNA, phospholipids, catecholamines and small molecules.
It is made from methionine and ATP by methionine adenosyltransferase, which is unusual in cleaving all three phosphates from ATP in a single reaction.
After the methyl group is handed over, S-adenosylhomocysteine is hydrolysed to adenosine and homocysteine, and S-adenosylhomocysteine itself inhibits most methyltransferases, so the SAMe to SAH ratio is what actually sets methylation capacity.
Homocysteine is either remethylated back to methionine, using methylfolate and vitamin B12 through methionine synthase or betaine through BHMT, or committed to cysteine by the vitamin B6 dependent transsulfuration enzymes.
Where SAM-e (S-Adenosylmethionine) comes from.
Yeast makes it. A selected brewer's yeast strain is fed sugar and methionine until it stockpiles the molecule inside its cells, then the cells are broken open and the compound is pulled out on a resin and locked into a stable salt. It is handled cold, acidic and dry the whole way, because the free molecule falls apart quickly.
Built by fermentation, the same way vitamin B12 and many amino acids are made at scale. Controlled conditions, consistent output.
Glucose or molasses supplies carbon and energy, with L-methionine fed into the medium as the direct precursor
A selected Saccharomyces cerevisiae strain is grown under conditions that make it accumulate S-adenosylmethionine intracellularly, since the enzyme runs faster than the cell consumes the product
Harvested biomass is lysed and the aqueous extract is acidified promptly, because the sulfonium centre degrades at neutral pH
The cationic molecule is captured on a cation exchange resin and eluted away from nucleotides and cell debris
The purified cation is combined with p-toluenesulfonic acid and sulfuric acid, or with 1,4-butanedisulfonic acid, then crystallised as the stabilised salt
Lots are assayed by chromatography for total SAMe and for the proportion present as the active (S,S) form, since the inactive diastereomer accumulates over time
The salt is compressed and enteric-coated, then blistered under low humidity because the material takes up water readily
Getting SAM-e (S-Adenosylmethionine) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- S-adenosylmethionine analogues acted as pharmacological chaperones at cystathionine beta-synthase, confirming that SAMe binds a regulatory site on the enzyme and stabilises its active conformation.In vitro study. Philipp TM et al., 2026 (International Journal of Biological Macromolecules). PMID 41478486 ↗
- The authors review S-adenosylmethionine as the universal methyl donor for DNA and histone methylation and discuss its evaluation in adults with low mood and early-life adversity.Narrative review. Alkema A et al., 2026 (Epigenomics). PMID 42027147 ↗
- A systematic review and meta-analysis of pharmacological interventions in milder low mood, in which S-adenosylmethionine appears among the agents assessed; the review reports pooled estimates rather than a finding specific to it.Meta-analysis. Urata M et al., 2025 (Neuropsychopharmacology Reports). PMID 40014460 ↗
- Loss of the SIN-3 coregulator narrowed the animals' ability to adapt to different diets through a vitamin B12 dependent route, which is the same B12-dependent step that regenerates methionine for SAMe synthesis.Animal study. Palladino F et al., 2026 (G3). PMID 41968086 ↗
- Maternal methionine supplementation was associated with altered N6-methyladenosine RNA methylation and skeletal muscle development in offspring, consistent with methionine intake shaping methyl-donor availability.Animal study. Gao M et al., 2026 (Animal Nutrition). PMID 42290959 ↗
- Prenatal availability of methyl nutrients was associated with differences in mesolimbic dopaminergic circuitry and systemic inflammatory markers in the offspring; these are markers and structural measures, not behavioural outcomes.Animal study. Di Pierdomenico C et al., 2026 (Journal of Neurochemistry). PMID 42141807 ↗
- A vitamin D receptor to spermidine axis acted through DNA methyltransferases in granulosa cells, linking polyamine supply, which draws on decarboxylated SAMe, to methylation activity.In vitro study. Chen H et al., 2026 (International Journal of Biological Sciences). PMID 42212335 ↗
- Characterisation of a spermidine synthase confirmed that decarboxylated S-adenosylmethionine is the aminopropyl donor for spermidine synthesis.In vitro study. Choi JY et al., 2026 (Pathogens). PMID 42075759 ↗
These are the studies our verdict leans on, chosen from the 8 we read for SAM-e (S-Adenosylmethionine). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.